Phase I Study of ZD4054 (Zibotentan) and Docetaxel in Patients With Metastatic HRPC

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
AstraZeneca
ClinicalTrials.gov Identifier:
NCT00314782
First received: April 13, 2006
Last updated: March 11, 2013
Last verified: March 2010
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: March 2009
  Primary Completion Date: March 2008 (Final data collection date for primary outcome measure)